The Nebraska Department of Health and Human Services (DHHS) is implementing a preferred drug list (PDL) and Supplemental Rebate Program for Nebraska Medicaid. DHHS has retained Magellan Medicaid Administration, Inc. to provide PDL management and supplemental rebate contracting services.
As part of the state's effort to control costs and provide clinically sound drug therapy for recipients, Provider Synergies, Magellan Medicaid Administration's sister company, will work with the Nebraska Pharmaceutical and Therapeutics Committee (P&T) and DHHS to expand the selection of preferred medications based on a review of the relative clinical effectiveness and cost of products within selected therapeutic classes. The intent of the PDL is to achieve quality pharmaceutical care for recipients enrolled in the Department's Medicaid fee-for-service programs while providing significant state savings.
Provider Synergies provides expert clinical staffing and support to Nebraska Medicaid including support of the P&T Committee, PDL development and ongoing management, supplemental rebate negotiation and comprehensive reporting services.
For more information about the Nebraska Medicaid Pharmacy Services, visit https://nebraska.fhsc.com.
P&T Committee Meeting Information
The next Pharmaceutical and Therapeutics (P&T) Committee meeting will be held on November 2, 2016 at:
Mahoney State Park
Peter Kiewit Lodge
28500 West Park Hwy
Ashland, NE 68003
P&T Committee Meeting Public Testimony
Participation in the Supplemental Rebate Process for Nebraska Medicaid
This state is now participating in the TOP$ program.
Once your company has provided contact information to Provider Synergies, your company's designated representatives will be notified when one or more of your products are under consideration for the PDL.